Text size

Cannabis shares were mostly higher Wednesday, ahead of a Congressional hearing on the obstacles facing cannabis companies when it comes to opening and maintaining bank accounts.

A subcommittee of the Democratic-controlled House Financial Services Committee will meet to hear testimony on the topic at 2 p.m. Eastern time. For now, cannabis companies are unable to hold accounts at federally backed banks, because weed is still subject to a federal ban, another issue that is hampering the development of the sector in those states that have legalized cannabis for medical or recreational use.

U.S. congressional Democratic leaders have circulated a draft of a bill that would give companies a clearer path to banking, according to Marijuana Moment, a website that works with activists, industry representatives and policy makers on trends affecting cannabis.

Related:Constellation Brands’ Move Into Marijuana Is Looking Better and Better

The technology underpinning cryptocurrencies could make stock trading faster and cheaper. But it will be some time before the financial services industry can put blockchain to work.

Democrats are looking at other legislative measures in 2019 to promote the sector amid concerns that Canada won a big first-mover advantage when it fully legalized cannabis last October.

Yaël Ossowski, deputy director at the cannabis advocacy group Consumer Choice Center, urged lawmakers to push for banking reform, outlining the risks facing companies forced to operate as cash-only businesses.

“Higher risk means cannabis companies face additional costs,” Ossowski said in a statement. “They have to hire security guards for transporting cash and paying local and state taxes, hire additional accountants to understand how to comply with existing rules and dedicate hours to organizing cash for payroll and business expenses. That ends upraising the cost of the product.”

Colorado, which is one of the states that has legalized cannabis for medical and recreational use, released its sales and tax revenue data for 2018 on Tuesday, and said sales have topped $6 billion since Jan. 1, 2014, the date that adult-use sales started in the state.

Cannabis sales topped $1.55 billion in 2018, above the just over $1.5 billion posted in 2017, according to the Colorado Department of Revenue.

Related:Marijuana Stocks Are Rallying After Aurora Cannabis Posted Earnings

Tax, license and fee revenue from cannabis exceeded $266.5 million in 2018, up from more than $247 million in 2017. To date, the state has collected more than $927 million in tax revenue since Jan. 1. 2014, including numbers for January of 2019.

Canada’s Canopy Growth shares (ticker: CGC) were up 2.3% ahead of earnings scheduled for Friday. Benchmark analyst Mike Hickey said he expects the company to benefit from initial shipments into the Canadian adult-use market and that future product offering, including edibles and beverages, will help drive growth.

Hickey is expecting sales of C$236 million ($178.5 million), below the company’s own guidance of C$284 million.

“We are cautious over near term supply limitations and nascent retail infrastructure (that) could challenge prior view,” Hickey wrote in a note. The analyst rates the stock a buy and has a C$100 price target, which is about 67% above its current trading level.

U.S.-listed shares of Canada’s Aurora Cannabis (ACB) were up 1.5%. That company, which reported earnings for its fiscal second quarter on Monday, said Wednesday that High Tide (HTDEF), a company it invested $10 million in via a convertible bond offering in December, has already met some of its growth targets.

In January, High Tide opened three more retail stores in Alberta, bringing the total to seven; it has preliminary agreements for retail locations in Saskatchewan, and will assist in operating 25 stores in Ontario. It has also listed its stock on the Frankfurt stock exchange under the ticker symbol 2LY. High Tide’s Canadian shares were up 1%.

Elsewhere in the sector, Cronos Group (CRON) was up 1.2%, Aphria (APHA) was up 2.7%, and Tilray (TLRY) was up 0.7%.

Hexo (HEXO) was up 1.2%, Aleafia Health (ALEF) was up 6%, and MedMen Enterprise (MMNFF) was up 1.4%.

The ETFMG Alternative Harvest ETF (MJ) was up 1%, and the Horizons Marijuana Life Sciences ETF (HMMJ) was up 1.2%.

The S&P 500 was up 0.5% and the Dow Jones Industrial Average was up 0.6%.

This article originally appeared on MarketWatch.

Comments? E-mail us at editors@barrons.com